According to a new report Global Atherectomy Devices Market, published by KBV Research, The Global Atherectomy Devices Market size is expected to reach $900.7 million by 2025, rising at a market growth of 6.8% CAGR during the forecast period. The North America market dominated the Global Atherectomy Devices Market by Region in 2018, and would continue to be a dominant market till 2025; thereby, achieving a market value of $394.2 Million by 2025, growing at a CAGR of 6.2 % during the forecast period.The Europe market is expected to witness a CAGR of 6.4% during (2019 - 2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 8.2% during (2019 - 2025).
Based on Type, the Directional Atherectomy market dominated the Global Atherectomy Devices Market by Type in 2018, and would continue to be a dominant market till 2025; thereby, achieving a market value of $304.6 Million by 2025, growing at a CAGR of 6 % during the forecast period. The Rotational Atherectomy market is expected to witness a CAGR of 7.1% during (2019 - 2025).
The North America market dominated the Global Rotational Atherectomy Market by Region in 2018, and would continue to be a dominant market till 2025; thereby, achieving a market value of $115.3 Million by 2025, growing at a CAGR of 6.4 % during the forecast period.The Europe market is expected to witness a CAGR of 6.7% during (2019 - 2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 8.5% during (2019 - 2025).
The key market players actively involved in the atherectomy devices market include Boston Scientific Corporation, Medtronic (Covidien), Cardiovascular Systems Inc., Spectranetics, Avinger Inc., Volcano Corporation, Koninklijke Philips N.V, ST. Jude Medical, Straub Medical AG, Cardinal Health (Cordis), BARD Peripheral Vascular, and Terumo IS. Market players are taking step-by-step approaches to leverage business possibilities. Companies focus on creative market-space competitive initiatives.
For example, in July 2018, Cardiovascular Systems signed an agreement with OrbusNeich for selling its coronary and peripheral Orbital Atherectomy Systems (OAS) in other countries. In the same month, the company collaborated with Aerolase Corporation for developing a new laser atherectomy device for physicians which can be used more effectively in the treatment of multiple forms of arterial disease.
In December 2015, Medtronic acquired Covidien to enhance its business in developing Atherectomy Device. In June 2017, Koninklijke Philips N.V. took over Spectranetics for expansion of image-guided therapy business group.
Full Report:https://www.kbvresearch.com/atherectomy-devices-market/
In March 2018, Terumo Corporation acquired assets related to the large bore vascular closure device from Medeon Biodesign, Inc. for enhancement of its product portfolio. In January 2019, Terumo IS expanded its reach to Canada by opening a new office in Vaughan, Ontario focusing on the expansion of its business.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cardiovascular Systems Inc., Avinger Inc., Straub Medical AG, Boston Scientific Corporation, Medtronic PLC (Covidien), Koninklijke Philips N.V., Cardinal Health, Inc. (Cordis), Terumo Corporation (Terumo IS), Abbott Laboratories and B. Braun Melsungen AG.
By Type
By Geography
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
